September 24, 2011

THE JAK-STAT PATHWAY: 20 YEARS FROM DISCOVERY TO DRUGS

September 22-24, 2011

Natcher Conference Center

National Institutes of Health, Bethesda, MD

Celebrating the 20th year of Jak-STAT research, highlighting recent basic developments in the field, relevance to diseases and new therapeutics

Registration is required for this meeting. Registration is now CLOSED.

Organizers

John O’Shea - NIH/NIAMS
James Darnell - Rockefeller University
Richard Jove - City of Hope
David Levy - NYU
Warren Leonard - NIH/NHLBI
Lothar Hennighausen - NIH/ NIDDK

Scientific Topics

  • Jaks & Jak Inhibitors
  • Jaks & Cancer
  • Biology & Structure of STATs
  • STATs in Immunoregulation
  • STATs in Development
  • STATs & Cancer
  • STATs & Infectious Disease

Funding provided by:

Invited Speakers

  • Christopher Garcia - Stanford University
  • James Clark - Pfizer
  • Anthony Green - Cambridge Institute for Medical Research
  • Jordan Fridman - Incyte
  • Louis Staudt - NIH/NCI
  • George Stark - Lerner Institute
  • Andrew Larner - Medical College of Virginia
  • Nadya Tarasova - NIH/NCI
  • Mark Kaplan - Indiana University
  • Yuka Kanno - NIH/NIAMS
  • Riitta Lahesmaa - Turku Center
  • Christine Watson - Cambridge University
  • Willis Li - UCSD
  • Robert Schreiber - Washington University
  • Hua Yu - City of Hope
  • John McMurray - MD Anderson Cancer Center
  • David Frank - Dana-Farber Cancer Institute
  • Garry Nolan - Stanford University
  • Giorgio Inghirami - University of Turin
  • Jennifer Grandis - University of Pittsburgh
  • Richard Moriggl - Boltzmann Institute
  • Valeria Poli - University of Turin
  • Jean-Laurent Casanova - Rockefeller University
  • Steve Holland - NIH/NIAID
  • Christine Biron - Brown University
  • Curt Horvath - Northwestern University
  • Manfred Boehm - NIH/NHLBI
  • Isabelle Dusanter-Fourt - Institut Cochin
Last Reviewed: